Quarterly report pursuant to Section 13 or 15(d)

NET LOSS PER SHARE (Tables)

v3.22.1
NET LOSS PER SHARE (Tables)
9 Months Ended
Mar. 31, 2022
NET LOSS PER SHARE  
Summary of Potential Common Stock Equivalents were Excluded from the Computation of Diluted Net Loss Per Share As of March 31, 2022 and 2021, the following outstanding potential common stock equivalents were excluded from the computation of diluted net loss per share since the impact of inclusion was anti-dilutive (in thousands):

    

2022

    

2021

Stock options

 

1,590

 

874

Warrants

 

1,158

 

1,437

Total

 

2,748

 

2,311

Schedule of Weighted Average Shares Outstanding

    

Three Months Ended

Nine Months Ended

March 31, 

March 31, 

    

2022

    

2021

2022

    

2021

Common Stock

15,557

8,352

12,735

7,445

2021 PFWs

1,661

1,013

Total

17,218

8,352

13,748

7,445